Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 5/20 | 0.59 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.48 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PRKDC | P78527 | 3/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.43 |
| ▸ | FLT3 | P36888 | 2/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.42 |
| ▸ | CHRNA5 | P30532 | 2/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29293558 | 0.99 | CYP11B2 (0.61) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29293489 | 0.96 | CYP11B2 (0.66) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29293486 | 0.96 | CYP11B2 (0.66) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29294221 | 0.94 | CYP11B2 (0.55) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29293560 | 0.92 | CYP11B2 (0.57) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29293718 | 0.92 | CYP11B2 (0.57) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29293685 | 0.92 | CYP11B2 (0.57) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29293509 | 0.92 | CYP11B2 (0.50) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29293688 | 0.91 | CYP11B2 (0.59) | CYP11B2CYP11B1CYP17A1NPY5RLMNA | |
| SCHEMBL29293508 | 0.91 | CYP11B2 (0.59) | CYP11B2CYP11B1CYP17A1NPY5RLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | OR10J3, ORMDL3, OR51E2 | CYP11B2 980/4885CYP11B1 1292/4885CYP17A1 1625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.